Tag Eric Horlick

As the twenty-first century progresses, a new chapter in cardiac therapeutics is being written with the development of transcatheter valve technologies. Percutaneous pulmonary valve implantation (PPVI) has the distinction of being the first percutaneous valve replacement in humans and has…

Acknowledgment Dr. Horlick is supported by the Peter Munk Chair in Structural Heart Disease. Cardiac catheterization remains a fundamental modality for the diagnosis and interventional treatment of adult congenital heart disease (ACHD); however, there has been a noticeable change in…